Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancer

Brachytherapy

Volumn 6, Issue 1, 2007, Pages 49-52

  Kälkner, Karl Mikael ^a   Bengtsson, Emil ^a   Eriksson, Simone ^a   Holmberg, Carina ^a   Nilsson, Sten ^a   Levitt, Seymour ^a,b   Lundell, Marie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Dosimetry; High dose rate brachytherapy; Prostate cancer; Thermoluminescence dosimeters

Indexed keywords

IRIDIUM 192;

ADULT; AGED; ANUS; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DOSIMETRY; DRUG MEGADOSE; HUMAN; IN VIVO STUDY; NEEDLE; PHANTOM; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; THERMOLUMINESCENCE DOSIMETER; TRANSPORT KINETICS;

AGED; AGED, 80 AND OVER; ANAL CANAL; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PHANTOMS, IMAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; THERMOLUMINESCENT DOSIMETRY;

EID: 33846576536     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2006.08.008     Document Type: Article

References (9)

1. Cancer Incidence in Sweden 2002. Vol. 2003: The National Board of Health and Welfare Centre for Epidemiology. http://www.sos.sc/sos/statisti.htm, December 2003.
2. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
3. Wachter S., Gerstner N., Goldner G., et al. Rectal sequelae after conformal radiotherapy of prostate cancer: Dose-volume histograms as predictive factors. Radiother Oncol 59 (2001) 65-70
4. Vordermark D., Schwab M., Ness-Dourdoumas R., et al. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol 69 (2003) 209-214
5. Borghede G., Hedelin H., Holmang S., et al. Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol 44 (1997) 237-244
6. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer. I. Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 47 (2000) 103-113
7. Yeoh E.E., Botten R., Russo A., et al. Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys 47 (2000) 915-924
8. al-Abany M., Helgason A.R., Cronqvist A.K., et al. Dose to the anal sphincter region and risk of fecal leakage. Acta Oncol 43 (2004) 117-118
9. Anagnostopoulos G., Baltas D., Geretschlaeger A., et al. In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 1183-1191